News

FILTER BY:
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
PayPal’s AI announcement is ‘shockingly unshocking’, says Mizuho’s Dan DolevPayPal’s AI announcement is ‘shockingly unshocking’, says Mizuho’s Dan Dolev
News

PayPal’s AI announcement is ‘shockingly unshocking’, says Mizuho’s Dan Dolev

January 26, 2024
Mizuho’s life insurance swaptions notional climbs 575% in a yearMizuho’s life insurance swaptions notional climbs 575% in a year
News

Mizuho’s life insurance swaptions notional climbs 575% in a year

January 24, 2024
Medical device companies ‘clear beneficiary’ following Humana’s warning, says Mizuho’s Jared HolzMedical device companies ‘clear beneficiary’ following Humana’s warning, says Mizuho’s Jared Holz
News

Medical device companies ‘clear beneficiary’ following Humana’s warning, says Mizuho’s Jared Holz

January 19, 2024
Bitcoin ETFs not good for Coinbase: Mizuho's DolevBitcoin ETFs not good for Coinbase: Mizuho's Dolev
News

Bitcoin ETFs not good for Coinbase: Mizuho's Dolev

January 13, 2024
Price compression of bitcoin trading begins today, says Mizuho’s Dan DolevPrice compression of bitcoin trading begins today, says Mizuho’s Dan Dolev
News

Price compression of bitcoin trading begins today, says Mizuho’s Dan Dolev

January 12, 2024
Eli Lilly’s DTC obesity drug push ‘not necessarily an industry game changer’: Mizuho’s Jared HolzEli Lilly’s DTC obesity drug push ‘not necessarily an industry game changer’: Mizuho’s Jared Holz
News

Eli Lilly’s DTC obesity drug push ‘not necessarily an industry game changer’: Mizuho’s Jared Holz

January 5, 2024
Mizuho’s Holz on weight loss drugs: Lilly and Novo Nordisk are in excellent shape fundamentallyMizuho’s Holz on weight loss drugs: Lilly and Novo Nordisk are in excellent shape fundamentally
News

Mizuho’s Holz on weight loss drugs: Lilly and Novo Nordisk are in excellent shape fundamentally

January 4, 2024
Mizuho Americas hires Bill Featherston as managing director and head of researchMizuho Americas hires Bill Featherston as managing director and head of research
Press Release

Mizuho Americas hires Bill Featherston as managing director and head of research

January 3, 2024
Obesity drug enthusiasm can continue in 2024: Mizuho’s Jared HolzObesity drug enthusiasm can continue in 2024: Mizuho’s Jared Holz
News

Obesity drug enthusiasm can continue in 2024: Mizuho’s Jared Holz

December 28, 2023
back-to-top-blue